Product Description
CISAPRIDE (SIS a pride) is used to treat heartburn in patients with gastroesophageal reflux disease (GERD). Because of the serious risks associated with this medicine it should only be used when lifestyle changes and other medicines have not worked. (Sourced from: https://my.clevelandclinic.org/health/drugs/18304-cisapride-tablets)
Mechanisms of Action: 5-HT4 Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Brazil | Bulgaria | Canada | Chile | Colombia | Dominican Republic | Germany | India | Indonesia | Ireland | Italy | Mexico | New Zealand | Pakistan | Peru | Poland | Portugal | Slovenia | South Africa | Taiwan | Turkey | United Kingdom | Uruguay | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|